CarsonAllaria Wealth Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-98
Closed -$5.61K 369
2024
Q3
$5.61K Hold
98
﹤0.01% 302
2024
Q2
$5.13K Hold
98
﹤0.01% 291
2024
Q1
$3.99K Hold
98
﹤0.01% 304
2023
Q4
$3.62K Hold
98
﹤0.01% 274
2023
Q3
$3.74K Buy
98
+60
+158% +$2.46K ﹤0.01% 273
2023
Q2
$1.37K Buy
+38
New +$1.3K ﹤0.01% 337

Other funds holding HALO

CarsonAllaria Wealth Management's HALO Position: Q4 2024 in Review

CarsonAllaria Wealth Management sold out of Halozyme (HALO) in Q4 2024, closing a stake of 98 shares — an estimated $5.61K sold.

CarsonAllaria Wealth Management first reported a position in HALO in Q2 2023 and held it in 6 quarters. The position peaked at $5.61K in Q3 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • CarsonAllaria Wealth Management reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 98 Halozyme shares in Q4 2024, an estimated $5.61K.
  • CarsonAllaria Wealth Management first reported a position in Halozyme in Q2 2023 and held it in 6 quarters.
  • CarsonAllaria Wealth Management's Halozyme position peaked at $5.61K in Q3 2024.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on CarsonAllaria Wealth Management's 13F filing for Q4 2024, filed 27 Jan 2025.